FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2073130801> ?p ?o ?g. }

• W2073130801 endingPage "473" @default.
• W2073130801 startingPage "468" @default.
• W2073130801 abstract "The purpose of our study is to examine the capacity of cetuximab to reverse radiation resistance and investigate molecular mechanisms in human radiation-resistant esophageal carcinoma cell line KYSE-150R.The radioresistant cell line KYSE-150R was established by using fractionated irradiation (FIR). The KYSE-150R cell line was exposed to radiation, treatment with cetuximab, and combined treatment. Cell cycle distribution and apoptosis were analyzed using flow cytometry. Radiation survival was analyzed using clonogenic assays. RT(2) profiler PCR array was performed to analyze EGF/PDGF signaling pathway genes.The established esophageal carcinoma cell line KYSE-150R showed higher radioresistance than parental cell line. Cetuximab could reverse the radiation resistance of KYSE-150R cells. Cell cycle analysis showed that combination with radiation and cetuximab resulted in the accumulation of cells in G1 and G2/M phases, with the reduction of cells within the S phase. Cetuximab enhanced the apoptosis induced by radiation. RT(2) profiler array showed that some intracellular signaling genes deriving from EGF/PDGF signaling pathway regulated by cetuximab.Irradiation combined with EGFR blocked by cetuximab may reverse the resistance to radiation in radioresistant esophageal carcinoma cell. The mechanisms may include cell cycle perturbation and enhancement of radiation-induced apoptosis. Further studies are needed to evaluate the role of cetuximab in combination with radiotherapy in the management of esophageal carcinoma." @default.
• W2073130801 created "2016-06-24" @default.
• W2073130801 creator A5008581844 @default.
• W2073130801 creator A5022193491 @default.
• W2073130801 creator A5028098930 @default.
• W2073130801 creator A5033482016 @default.
• W2073130801 creator A5037147271 @default.
• W2073130801 creator A5066716873 @default.
• W2073130801 creator A5078442277 @default.
• W2073130801 date "2009-12-01" @default.
• W2073130801 modified "2023-09-26" @default.
• W2073130801 title "Reverse resistance to radiation in KYSE-150R esophageal carcinoma cell after epidermal growth factor receptor signal pathway inhibition by cetuximab" @default.
• W2073130801 cites W1964158918 @default.
• W2073130801 cites W1995661224 @default.
• W2073130801 cites W1999250974 @default.
• W2073130801 cites W2006216255 @default.
• W2073130801 cites W2010397777 @default.
• W2073130801 cites W2014134684 @default.
• W2073130801 cites W2020830322 @default.
• W2073130801 cites W2023575200 @default.
• W2073130801 cites W2037451557 @default.
• W2073130801 cites W2048281158 @default.
• W2073130801 cites W2059167706 @default.
• W2073130801 cites W2063380944 @default.
• W2073130801 cites W2064326390 @default.
• W2073130801 cites W2064751197 @default.
• W2073130801 cites W2070151637 @default.
• W2073130801 cites W2091573051 @default.
• W2073130801 cites W2105268795 @default.
• W2073130801 cites W2107277218 @default.
• W2073130801 cites W2114177305 @default.
• W2073130801 cites W2155384808 @default.
• W2073130801 cites W2160551594 @default.
• W2073130801 cites W2164837623 @default.
• W2073130801 cites W2168213749 @default.
• W2073130801 cites W3022968781 @default.
• W2073130801 cites W4248860264 @default.
• W2073130801 doi "https://doi.org/10.1016/j.radonc.2009.08.008" @default.
• W2073130801 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19744737" @default.
• W2073130801 hasPublicationYear "2009" @default.
• W2073130801 type Work @default.
• W2073130801 sameAs 2073130801 @default.
• W2073130801 citedByCount "46" @default.
• W2073130801 countsByYear W20731308012012 @default.
• W2073130801 countsByYear W20731308012013 @default.
• W2073130801 countsByYear W20731308012014 @default.
• W2073130801 countsByYear W20731308012015 @default.
• W2073130801 countsByYear W20731308012016 @default.
• W2073130801 countsByYear W20731308012017 @default.
• W2073130801 countsByYear W20731308012018 @default.
• W2073130801 countsByYear W20731308012019 @default.
• W2073130801 countsByYear W20731308012020 @default.
• W2073130801 countsByYear W20731308012021 @default.
• W2073130801 countsByYear W20731308012022 @default.
• W2073130801 countsByYear W20731308012023 @default.
• W2073130801 crossrefType "journal-article" @default.
• W2073130801 hasAuthorship W2073130801A5008581844 @default.
• W2073130801 hasAuthorship W2073130801A5022193491 @default.
• W2073130801 hasAuthorship W2073130801A5028098930 @default.
• W2073130801 hasAuthorship W2073130801A5033482016 @default.
• W2073130801 hasAuthorship W2073130801A5037147271 @default.
• W2073130801 hasAuthorship W2073130801A5066716873 @default.
• W2073130801 hasAuthorship W2073130801A5078442277 @default.
• W2073130801 hasConcept C121608353 @default.
• W2073130801 hasConcept C126322002 @default.
• W2073130801 hasConcept C143998085 @default.
• W2073130801 hasConcept C170493617 @default.
• W2073130801 hasConcept C190283241 @default.
• W2073130801 hasConcept C206684579 @default.
• W2073130801 hasConcept C2779438470 @default.
• W2073130801 hasConcept C2779998722 @default.
• W2073130801 hasConcept C29537977 @default.
• W2073130801 hasConcept C502942594 @default.
• W2073130801 hasConcept C509974204 @default.
• W2073130801 hasConcept C526805850 @default.
• W2073130801 hasConcept C55493867 @default.
• W2073130801 hasConcept C58962609 @default.
• W2073130801 hasConcept C71924100 @default.
• W2073130801 hasConcept C86803240 @default.
• W2073130801 hasConceptScore W2073130801C121608353 @default.
• W2073130801 hasConceptScore W2073130801C126322002 @default.
• W2073130801 hasConceptScore W2073130801C143998085 @default.
• W2073130801 hasConceptScore W2073130801C170493617 @default.
• W2073130801 hasConceptScore W2073130801C190283241 @default.
• W2073130801 hasConceptScore W2073130801C206684579 @default.
• W2073130801 hasConceptScore W2073130801C2779438470 @default.
• W2073130801 hasConceptScore W2073130801C2779998722 @default.
• W2073130801 hasConceptScore W2073130801C29537977 @default.
• W2073130801 hasConceptScore W2073130801C502942594 @default.
• W2073130801 hasConceptScore W2073130801C509974204 @default.
• W2073130801 hasConceptScore W2073130801C526805850 @default.
• W2073130801 hasConceptScore W2073130801C55493867 @default.
• W2073130801 hasConceptScore W2073130801C58962609 @default.
• W2073130801 hasConceptScore W2073130801C71924100 @default.
• W2073130801 hasConceptScore W2073130801C86803240 @default.
• W2073130801 hasIssue "3" @default.
• W2073130801 hasLocation W20731308011 @default.
• W2073130801 hasLocation W20731308012 @default.

• next